HC Deb 03 March 1997 vol 291 cc517-9W
Mr. Flynn

To ask the Secretary of State for Health if he will list the members of the Committee on Safety of Medicines indicating(a) the organisations that they represent, (b) the organisations nominating them to sit on the committee, (c) other voluntary and paid employment that they undertake and (d) other areas of expertise that they have: and if he will make a statement. [17848]

Mr. Malone

Following is the membership of the Committee on Safety of Medicines, members' qualifications and expertise and their primary place of employment:

  • Professor M. D. Rawlins BSc MD FRCP(Lon) FRCP(Ed) FFPM: Chairman
  • Professor of Clinical Pharmacology, Newcastle University;
  • Professor T. R. E. Barnes MD FRCPsych
  • Professor of Clinical Psychiatry, London University;
  • Professor A. M. Breckenridge CBE MD MSc FRCP FRCPE FRSE: Vice Chairman
  • Professor of Clinical Pharmacology, Liverpool University;
  • Dr. K. L. Costeloe MB BChir FRCP
  • Head of Academic Department of Child Health and Reader in Neonatal Medicine, St. Bartholomew's and the Royal London School of Medicine and Dentistry;
  • Professor J. H. Darbyshire OBE MSc MB ChB FRCP
  • Head of the MRC's HIV Clinical Trials Centre, University College London Medical School;
  • Professor H. J. Dargie FRCP FESC
  • Consultant Cardiologist and Co-Director of CRI in Heart Failure, Glasgow University;
  • Professor D. S. Davies BSc PhD CChem FRSC
  • Professor of Biochemical Pharmacology, Royal Postgraduate Medical School, Hammersmith Hospital, London;
  • Dr. A. M. Douglas BSc MB ChB MRCGP DCH DRCOG
  • General Practitioner, Exeter;
  • 518
  • Professor G. W. Duff MA BM BCh PhD FRCP
  • Professor of Molecular Medicine. Sheffield University;
  • Dr. S. J. Eykyn FRCP FRCPath
  • Reader (Hon Con) in Clinical Microbiology, St. Thomas' Hospital, London;
  • Professor R. G. Finch FRCP FRCPath FFPM
  • Professor of Infectious Diseases, Nottinghan University;
  • Professor A. T. Florence CBE DSc FRSC FRSE FRPharmS
  • Dean of the School of Pharmacy, London University;
  • Professor E. C. Gordon-Smith FRCP FRCPath
  • Professor of Haematology, St. George's Hospital Medical School. London;
  • Professor K. Gull BSc PhD
  • Director of the Research and Graduate School, School of Biological Sciences, Manchester University;
  • Professor H. S. Jacobs MD FRCP FRCOG
  • Professor of Reproductive Endocrinology, University College and Middlesex School of Medicine, London;
  • Mrs. E. A. Kay MSc MRPharmS MCPP DMS
  • Director of Clinical Pharmacy, United Leeds Teaching Hospital Trust;
  • Dr. M. J. Kendall MD FRCP
  • Reader in Medicine, Birmingham University; Dr. B. J. Kirby MD MB ChB FRCP
  • Consultant Physician and Deputy Director Postgraduate Medical School, Exeter University;
  • Dr. S. Kumar MBBS MRCGP DCH DPMC
  • Principal in General Practice, Widnes, Cheshire and Member of the Department of Health's Advisory Committee on NHS Drugs;
  • Professor M. J. S. Langman BSc MD FRCP
  • Professor of Medicine and Dean of the Faculty of Medicine and Dentistry, Birmingham University;
  • Dr. A. V. P. MacKay OBE MA BSc PhD MB ChB FRCPsych FRCP
  • Medical Director of the Argyll and Bute NHS Trust and McIntosh Lecturer in Psychological Medicine, Glasgow University;
  • Professor J. M. Midgley BSc MSc PhD CChem FRSC FRPharmS;
  • Professor of Pharmaceutical and Medicinal Chemistry, Strathclyde University;
  • Professor B. K. Park BSc Phd MRCP
  • Professor of Pharmacology and Therapeutics, Liverpool University;
  • Professor B. L. Pentecost MD FRCP
  • Consultant Physician and Director of British Heart Foundation;
  • Professor J. C. Petrie FRCP(Ed) FRCP(Lon) FFPM
  • Professor of Clinical Pharmacology, Aberdeen University;
  • Professor L. L. Smith PhD FRCPath
  • Director of the MRC Toxicology Unit, Leicester University;
  • Dr. K. Vernier Jones MD FRCP
  • Senior Lecturer in Paediatric Nephrology, Cardiff Royal Infirmary;
  • Professor M. P. Vessey CBE MD FRCP FFPHM FRS
  • Professor of Public Health, Oxford University;
  • Professor I. V. D. Weller MD FRCP
  • Head of Department of Sexually Transmitted Diseases (a division of Pathology and Infectious Diseases), University College London Medical School.

The Committee on Safety of Medicines is an independent body of drug safety experts. Its members are appointed by the United Kingdom Health Ministers—the licensing authority—following consultations with appropriate organisations and on the recommendations of the Medicines Commission. The organisations consulted include professional associations such as the royal colleges, the pharmaceutical industry, and organisations concerned with the interests of consumers, women and ethnic minorities. Members do not represent organisations, but contribute by their individual expertise and judgment to the advice given by the committee to the licensing authority. In addition, members are required to follow a code of practice on relations with the pharmaceutical industry and to declare their interests which are published annually.